Peptide Therapeutics Market Size, Trends, Analysis, and Outlook By Application (Cancer, Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Gastrointestinal Disorders, Infectious Diseases, Pain, Dermatological Disorders, Neurological Disorders, Renal Disorders, Others), By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, Others), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology), by Region, Country, Segment, and Companies, 2024-2030
The global Peptide Therapeutics market size is poised to register 7.25% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Peptide Therapeutics market across By Application (Cancer, Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Gastrointestinal Disorders, Infectious Diseases, Pain, Dermatological Disorders, Neurological Disorders, Renal Disorders, Others), By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, Others), By Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology).
The Peptide Therapeutics market is experiencing significant growth driven by the increasing prevalence of chronic diseases, advancements in peptide drug discovery and development, and growing applications of peptides in precision medicine, targeted therapy, and personalized healthcare. Peptide therapeutics represent a diverse class of drugs comprising short chains of amino acids with unique biochemical, pharmacological, and therapeutic properties, making them attractive candidates for the treatment of various medical conditions, including metabolic disorders, cardiovascular diseases, cancer, infectious diseases, and autoimmune disorders. Key factors driving market expansion include the expanding pipeline of peptide drug candidates targeting novel disease pathways, molecular targets, and biological processes implicated in disease pathogenesis, and the growing interest in peptide-based biologics, peptide hormones, peptide vaccines, and peptide mimetics as next-generation therapeutics offering improved efficacy, safety, and patient outcomes compared to conventional drugs. Additionally, advancements in peptide synthesis, peptide library screening, and structure-activity relationship (SAR) studies are driving innovation and accelerating the discovery and optimization of peptide drugs with enhanced pharmacokinetic profiles, target specificity, and tissue penetration properties. Moreover, the increasing adoption of peptide therapeutics in orphan disease indications, rare genetic disorders, and niche therapeutic areas with high unmet medical needs is driving investment and collaboration in peptide drug development programs, regulatory pathways, and market access initiatives. Furthermore, the growing trend towards personalized medicine, companion diagnostics, and biomarker-driven treatment strategies is creating opportunities for precision-targeted peptide therapies tailored to individual patient profiles, genetic mutations, and disease phenotypes. With the continuous focus on peptide engineering, drug delivery technologies, and translational research in peptide biology and pharmacology, the Peptide Therapeutics market is poised for further expansion in the coming years.
Peptide Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Peptide Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Peptide Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Peptide Therapeutics industry.
Key market trends defining the global Peptide Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Peptide Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Peptide Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Peptide Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Peptide Therapeutics industry
Leading Peptide Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Peptide Therapeutics companies.
Peptide Therapeutics Market Study- Strategic Analysis Review
The Peptide Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Peptide Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Peptide Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Peptide Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Peptide Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Peptide Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Peptide Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Peptide Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Peptide Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Peptide Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Peptide Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Peptide Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Peptide Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Peptide Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Peptide Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Peptide Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Peptide Therapeutics.
Peptide Therapeutics Market Company Profiles
The global Peptide Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, AstraZeneca, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Ipsen Pharma, Ironwood Pharmaceuticals Inc, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Radius Health Inc, Sanofi, Takeda Pharmaceutical Company Ltd, Teva Pharmaceutical Industries Ltd
Recent Peptide Therapeutics Market Developments
The global Peptide Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Peptide Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology
Geographical Segmentation:
Amgen Inc
AstraZeneca
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Ipsen Pharma
Ironwood Pharmaceuticals Inc
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Radius Health Inc
Sanofi
Takeda Pharmaceutical Company Ltd
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
The Peptide Therapeutics market is experiencing significant growth driven by the increasing prevalence of chronic diseases, advancements in peptide drug discovery and development, and growing applications of peptides in precision medicine, targeted therapy, and personalized healthcare. Peptide therapeutics represent a diverse class of drugs comprising short chains of amino acids with unique biochemical, pharmacological, and therapeutic properties, making them attractive candidates for the treatment of various medical conditions, including metabolic disorders, cardiovascular diseases, cancer, infectious diseases, and autoimmune disorders. Key factors driving market expansion include the expanding pipeline of peptide drug candidates targeting novel disease pathways, molecular targets, and biological processes implicated in disease pathogenesis, and the growing interest in peptide-based biologics, peptide hormones, peptide vaccines, and peptide mimetics as next-generation therapeutics offering improved efficacy, safety, and patient outcomes compared to conventional drugs. Additionally, advancements in peptide synthesis, peptide library screening, and structure-activity relationship (SAR) studies are driving innovation and accelerating the discovery and optimization of peptide drugs with enhanced pharmacokinetic profiles, target specificity, and tissue penetration properties. Moreover, the increasing adoption of peptide therapeutics in orphan disease indications, rare genetic disorders, and niche therapeutic areas with high unmet medical needs is driving investment and collaboration in peptide drug development programs, regulatory pathways, and market access initiatives. Furthermore, the growing trend towards personalized medicine, companion diagnostics, and biomarker-driven treatment strategies is creating opportunities for precision-targeted peptide therapies tailored to individual patient profiles, genetic mutations, and disease phenotypes. With the continuous focus on peptide engineering, drug delivery technologies, and translational research in peptide biology and pharmacology, the Peptide Therapeutics market is poised for further expansion in the coming years.
Peptide Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Peptide Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Peptide Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Peptide Therapeutics industry.
Key market trends defining the global Peptide Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Peptide Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Peptide Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Peptide Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Peptide Therapeutics industry
Leading Peptide Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Peptide Therapeutics companies.
Peptide Therapeutics Market Study- Strategic Analysis Review
The Peptide Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Peptide Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Peptide Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Peptide Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Peptide Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Peptide Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Peptide Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Peptide Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Peptide Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Peptide Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Peptide Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Peptide Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Peptide Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Peptide Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Peptide Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Peptide Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Peptide Therapeutics.
Peptide Therapeutics Market Company Profiles
The global Peptide Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, AstraZeneca, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Ipsen Pharma, Ironwood Pharmaceuticals Inc, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Radius Health Inc, Sanofi, Takeda Pharmaceutical Company Ltd, Teva Pharmaceutical Industries Ltd
Recent Peptide Therapeutics Market Developments
The global Peptide Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Peptide Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Amgen Inc
AstraZeneca
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Ipsen Pharma
Ironwood Pharmaceuticals Inc
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Radius Health Inc
Sanofi
Takeda Pharmaceutical Company Ltd
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Peptide Therapeutics Market Overview and Key Findings, 2024
1.2 Peptide Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Peptide Therapeutics Market Growth Opportunities to 2030
1.4 Key Peptide Therapeutics Market Trends and Challenges
1.4.1 Peptide Therapeutics Market Drivers and Trends
1.4.2 Peptide Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Peptide Therapeutics Companies
2. PEPTIDE THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Peptide Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Peptide Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PEPTIDE THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PEPTIDE THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Peptide Therapeutics Market, 2025
5.2 Asia Pacific Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Peptide Therapeutics Market, 2025
5.5 Europe Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Peptide Therapeutics Market, 2025
5.8 North America Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Peptide Therapeutics Market, 2025
5.11 South America Pacific Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Peptide Therapeutics Market, 2025
5.14 Middle East Africa Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Peptide Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Peptide Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Peptide Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Peptide Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Peptide Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Peptide Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Peptide Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Peptide Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Peptide Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Peptide Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Peptide Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Peptide Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Peptide Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Peptide Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Peptide Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Peptide Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Peptide Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Peptide Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Peptide Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Peptide Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Peptide Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Peptide Therapeutics Industry Drivers and Opportunities
7. PEPTIDE THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PEPTIDE THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Peptide Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
AstraZeneca
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Ipsen Pharma
Ironwood Pharmaceuticals Inc
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Radius Health Inc
Sanofi
Takeda Pharmaceutical Company Ltd
Teva Pharmaceutical Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Peptide Therapeutics Market Overview and Key Findings, 2024
1.2 Peptide Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Peptide Therapeutics Market Growth Opportunities to 2030
1.4 Key Peptide Therapeutics Market Trends and Challenges
1.4.1 Peptide Therapeutics Market Drivers and Trends
1.4.2 Peptide Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Peptide Therapeutics Companies
2. PEPTIDE THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Peptide Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Peptide Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PEPTIDE THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PEPTIDE THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Application
Cancer
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Gastrointestinal Disorders
Infectious Diseases
Pain
Dermatological Disorders
Neurological Disorders
Renal Disorders
Others
By Type
Generic
Innovative
By Type of Manufacturers
In-house
Outsourced
By Route of Administration
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Synthesis Technology
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Peptide Therapeutics Market, 2025
5.2 Asia Pacific Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Peptide Therapeutics Market, 2025
5.5 Europe Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Peptide Therapeutics Market, 2025
5.8 North America Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Peptide Therapeutics Market, 2025
5.11 South America Pacific Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Peptide Therapeutics Market, 2025
5.14 Middle East Africa Peptide Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Peptide Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Peptide Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Peptide Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Peptide Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Peptide Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Peptide Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Peptide Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Peptide Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Peptide Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Peptide Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Peptide Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Peptide Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Peptide Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Peptide Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Peptide Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Peptide Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Peptide Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Peptide Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Peptide Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Peptide Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Peptide Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Peptide Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Peptide Therapeutics Industry Drivers and Opportunities
7. PEPTIDE THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PEPTIDE THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Peptide Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
AstraZeneca
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Ipsen Pharma
Ironwood Pharmaceuticals Inc
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Radius Health Inc
Sanofi
Takeda Pharmaceutical Company Ltd
Teva Pharmaceutical Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
